Natural History of Anal Neoplasia in HIV-Infected Men |
United States |
HIV/AIDS |
|
|
HPV and AIDS Malignancies Clinical Trials Consortium (AMC) |
United States |
HIV/AIDS, Cancer/Oncology |
|
|
Doris Duke Clinical Research Fellowship (CRF) Program for Medical Students |
Kenya; Tanzania; India; Peru |
Residencies, Fellowships, and Postdoctoral Training |
|
|
Anal HPV Infection and ASIL in HIV+ and HIV- Women |
United States |
HIV/AIDS, Women's Health |
|
|
HPV and Cervix Neoplasia in a Large, Long Term HIV+ Cohort |
United States |
HIV/AIDS, Aging |
|
|
Women and Infants Transmission Study - Human Papillomavirus Protocol |
United States |
Infectious Disease, HIV/AIDS, Cancer/Oncology, Women's Health |
|
|
California Division Special Research Scholar Grant in HIV-Related Cancers |
United States |
HIV/AIDS, Cancer/Oncology |
|
|
Anal Human Papillomavirus (HPV) in Methamphetamine (MA) Using and Non-Using Men Who Have Sex with Men (MSM) in Los Angeles |
United States |
Infectious Disease, Cancer/Oncology, Substance Abuse, Risk Reduction and Prevention |
|
|
SMART Anal Dysplasia Sub-Study |
United States |
HIV/AIDS, Opportunistic Infection, Cancer/Oncology |
|
|
Merck Men's Efficacy Study, V501 |
United States |
Infectious Disease |
|
|
Doris Duke Clinical Research Fellowship (CRF) Program for Medical Students |
Kenya; Uganda; Tanzania; India |
Residencies, Fellowships, and Postdoctoral Training |
|
|
HPV Cervical Neoplasia in a Long-Term HIV+ Cohort |
United States |
Sexually Transmitted Infections (STIs), Cancer/Oncology, Women's Health |
|
|
UCSF Predoctoral Clinical Research Training Program |
United States |
Training and Capacity Building |
|
|
A Master Agreement: HPV Testing of Samples from the AIDS Malignancy Consortium |
India |
HIV/AIDS, Cancer/Oncology, Women's Health |
|
|
Doris Duke Charitable Foundation International Clinical Research Fellowship Program |
Kenya; Uganda; Tanzania; Zimbabwe; Ghana; Cambodia; Thailand; Nicaragua |
HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Oral Health, Neurology and Mental Health, Women's Health, Pediatrics, Newborn and Infant Health, Immigration and Migration, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training |
|
|
Epidemiologic Effects of ART on HIV-related Anal Cancer and Anal Dysplasia |
United States |
Infectious Disease, HIV/AIDS, Cancer/Oncology |
|
|
Cidofovir for Perianal Dysplasia in HIV Patients |
United States |
HIV/AIDS, Cancer/Oncology |
|
|
HIV Facilitated Paracellular Penetration of HPV across Mucosal Epithelium |
United States |
HIV/AIDS |
|
|
The Impact of Anogenital Human Papillomavirus in the Transmission of HIV in Urban Brazil: Phase II Study |
Brazil |
Infectious Disease, Pharmacology and Drug Treatment |
|
|
Marshalling Science for Global Health: A Bilateral Workshop |
Canada |
Health Systems Strengthening, Training and Capacity Building |
|
|
Determinants of Participation in an Anal Cancer Prevention Trial |
United States |
Cancer/Oncology |
|
|
HPV Testing of Samples from the AIDS Malignancy Consortium |
India |
HIV/AIDS |
|
|
Doris Duke Clinical Research Fellowship Renewal |
Kenya; Uganda; Tanzania; Zimbabwe; India; Cambodia |
Training and Capacity Building |
|
|
Incidence of HIV among Indian Men Who Have Sex with Men |
India |
HIV/AIDS, Epidemiology and Surveillance |
|
|
HPV-Related Neoplasia among HIV-Seropositive Indian Men Who Have Sex With Men |
India |
HIV/AIDS, Cancer/Oncology |
|
|
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females |
United States |
HIV/AIDS |
|
|
APTIMA HPV Clinical Study on Anal Specimens from Men Who Have Sex with Men (MSM) |
United States |
Sexually Transmitted Infections (STIs) |
|
|
International Clinical Research Fellowships for Medical Students |
Kenya; Uganda; Tanzania; Zimbabwe; India; Cambodia |
Residencies, Fellowships, and Postdoctoral Training |
|
|
Anal Cytology/HPV Testing Study |
United States |
Infectious Disease, Cancer/Oncology, Systematic Reviews and Guideline Development |
|
|
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26- Year-Old Men and 16- to 26- Year-Old Women |
South Africa; Malaysia; Thailand; Israel; Turkey; Denmark; Germany; Norway; Poland; Spain; Sweden; Mexico; Colombia; Peru; Canada |
Women's Health |
|
|
GINI: Gardasil Immunogenicity with Needle-free Injection-Safety and Immunogenicity of Gardasil using IM and ID needle-free injection delivery |
Thailand |
Sexually Transmitted Infections (STIs), Cancer/Oncology |
|
|
Thai Red Cross S&S, HPV TA008 |
Thailand |
Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology, Pharmacology and Drug Treatment |
|
|
HPV Testing Contract for UPR NIDCR-funded R21, "Detection of HPV infection in the oral cavity of Hispanics with and without periodontal disease" |
Puerto Rico |
Infectious Disease, Oral Health |
|
|
Thai Red Cross S&S, HN177 |
Thailand |
Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology |
|
|
A Phase I, Dose Escalation Study To Establish Safety of Leukocyte Interleukin, Injection [Multikine] for Treatment of Perianal Condylomata In Adult Men and Women Who Are HIV/HPV Co-infected |
United States |
HIV/AIDS, Opportunistic Infection, Cancer/Oncology |
|
|
Administrative Supplements to Cancer Centers Support Grants to Stimulate Collaborative HIV Malignancy Research in Low and Middle Income Countries |
Uganda |
HIV/AIDS, Cancer/Oncology, Women's Health |
|
|
HIV/HPV cancer prevention treatment and pathogenesis: Rwanda /Einstein Consortium |
Rwanda |
HIV/AIDS, Opportunistic Infection, Cancer/Oncology |
|
|
HPV testing of samples from the AIDS Malignancy Consortium |
Kenya; Uganda; India; Brazil |
HIV/AIDS, Opportunistic Infection, Cancer/Oncology |
|
|
ANCHOR (Anal Cancer/HSIL Outcomes Research) Study (AMC Supplement Administrative Core) |
United States |
Cancer/Oncology |
|
|
(PQ5) Role of HIV-associated cellular miRNAs in HPV 16-induced pathogenesis |
United States |
Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology |
|
|
(PQ4) Anal HPV infection and anal HSIL among HIV-infected MSM aged 50+ years |
United States |
Infectious Disease, HIV/AIDS, Cancer/Oncology |
|
|
The Microbiome and Anal Cancer Pathogenesis in HIV-infected Men who have Sex with Men |
United States |
Infectious Disease, HIV/AIDS, Cancer/Oncology |
|
|
New therapeutic HPV vaccines for HIV-infected men and women |
United States |
Genetics |
|
|
AMC-103: A Phase 2 Evaluation of VGX-3100, a Synthetic DNA Immunotherapy Targeting Human Papillomavirus 16 and 18 E6 and E7 Proteins, for Anal High-Grade Squamous Intraepithelial Lesions (HSIL) in HIV-Positive Individuals |
United States |
Infectious Disease, Sexually Transmitted Infections (STIs) |
|
|
Anal Dysplasia SCC Supplement for P30 Cancer Support Grant to Stimulate HIV/AIDS Cancer Research Projects NCI-designated Cancer Centers |
United States |
HIV/AIDS, Infectious Disease, Cancer/Oncology |
|
|
Next Generation of HPV and Cervical Cancer Research in HIV+ Women |
United States |
HIV/AIDS, Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology |
|
|